TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.

Tony Mok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.